Novartis upgraded to Equal Weight from Underweight at Barclays Barclays analyst Emmanuel Papadakis upgraded Novartis to Equal Weight following better than expected CANTOS results
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.